Late Gestational Diabetes Mellitus Diagnosis in Obese Women (NCT05510518) | Clinical Trial Compass
UnknownNot Applicable
Late Gestational Diabetes Mellitus Diagnosis in Obese Women
Israel150 participantsStarted 2022-08
Plain-language summary
In the current work, we aim to perform a prospective study that will investigate the relationship between maternal obesity (BMI \>30 kg/m2) and morbid obesity (BMI \>35 kg/m2) with a late GDM diagnosis (\>32 weeks), with an emphasis on obstetric and neonatal outcomes.
Who can participate
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Women with normal OGTT at weeks 24-28
. Women with BMI \>30 kg/m2
Exclusion criteria
. Multiple pregnancy
. Fetal defects
. Women who received steroids within the preceding week
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study focuses on obese and morbidly obese women — does my specific BMI or weight category make me a good or poor fit to discuss this kind of late gestational diabetes screening?
2The trial is looking at diagnosing GDM later in pregnancy using the OGTT test — if I haven't been tested yet, should I be asking for an OGTT now, and how would that timing compare to what this study is doing?
3The outcomes being tracked include serious complications like shoulder dystocia, newborn low blood sugar, jaundice, and polycythemia — how likely are these risks in my situation, and would earlier or later GDM diagnosis change how we manage them?
4The recruitment status for this trial is listed as unknown, so it's unclear whether it's actively enrolling — is this something worth pursuing, or should we focus on proven standard-of-care screening options available to me right now?
5Since this is a Phase NA observational-style study measuring diagnosis rates rather than testing a new treatment, would participating give me any direct benefit, or would it mainly contribute to research while my care continues as normal?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of obese women that will be diagnosed with late GDM diagnosis by the OGTT
Timeframe: through study completion, an average of 1 year